Treatment of Relapses in ANCA-Associated Vasculitis.
作者信息
McClure Mark, Jones Rachel B
机构信息
Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom; and.
Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
出版信息
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):967-969. doi: 10.2215/CJN.06250519. Epub 2019 Jun 28.
Abstract
摘要
相似文献
1
Treatment of Relapses in ANCA-Associated Vasculitis.抗中性粒细胞胞浆抗体相关血管炎复发的治疗
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):967-969. doi: 10.2215/CJN.06250519. Epub 2019 Jun 28.
2
Mycophenolate Mofetil Versus Cyclophosphamide for the Induction of Remission in Nonlife-Threatening Relapses of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Randomized, Controlled Trial.霉酚酸酯与环磷酰胺用于诱导抗中性粒细胞胞浆抗体相关血管炎非危及生命复发的缓解：随机对照试验
Clin J Am Soc Nephrol. 2019 Jul 5;14(7):1021-1028. doi: 10.2215/CJN.11801018. Epub 2019 Jun 28.
3
MYCYC: unravelling the long road ahead in ANCA-associated vasculitis.MYCYC：探索抗中性粒细胞胞浆抗体相关性血管炎的漫长前路
Ann Rheum Dis. 2020 May;79(5):e57. doi: 10.1136/annrheumdis-2019-215241. Epub 2019 Mar 20.
4
Response to: 'MYCYC, unravelling the long road ahead in ANCA-associated vasculitis' by Jain .对贾恩所著《MYCYC，揭示抗中性粒细胞胞浆抗体相关性血管炎的漫长前路》的回应
Ann Rheum Dis. 2020 May;79(5):e58. doi: 10.1136/annrheumdis-2019-215254. Epub 2019 Mar 20.
5
Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.在诱导缓解后仍为胞质型抗中性粒细胞胞质抗体阳性的新诊断的蛋白酶3抗中性粒细胞胞质抗体相关血管炎患者中，延长与标准硫唑嘌呤维持治疗的比较：一项随机临床试验
Nephrol Dial Transplant. 2016 Sep;31(9):1453-9. doi: 10.1093/ndt/gfw211. Epub 2016 May 30.
6
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.霉酚酸酯与环磷酰胺诱导 ANCA 相关性血管炎缓解的随机对照非劣效试验。
Ann Rheum Dis. 2019 Mar;78(3):399-405. doi: 10.1136/annrheumdis-2018-214245. Epub 2019 Jan 5.
7
Changing landscape of immunosuppression in ANCA-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎中免疫抑制格局的变化
Ann Rheum Dis. 2020 May;79(5):e59. doi: 10.1136/annrheumdis-2019-215123. Epub 2019 Feb 12.
8
Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.贝利尤单抗联合硫唑嘌呤维持治疗抗中性粒细胞胞质抗体相关性血管炎缓解的疗效和安全性：一项随机对照研究。
Arthritis Rheumatol. 2019 Jun;71(6):952-963. doi: 10.1002/art.40802. Epub 2019 Apr 16.
9
Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission.抗中性粒细胞胞质抗体相关性垂体血管炎肾缓解后无抗中性粒细胞胞质抗体升高的异位复发。
Intern Med. 2020 Dec 15;59(24):3187-3193. doi: 10.2169/internalmedicine.4731-20. Epub 2020 Aug 12.
10
Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3.影响抗中性粒细胞胞浆抗体（针对蛋白酶 3）连续检测临床效用的因素。
Arthritis Rheumatol. 2016 Jul;68(7):1700-10. doi: 10.1002/art.39637.
引用本文的文献
1
Advances in the Assessment and Treatment of Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis.抗中性粒细胞胞浆抗体相关肾小球肾炎的评估与治疗进展
J Inflamm Res. 2024 Dec 31;17:11881-11900. doi: 10.2147/JIR.S494848. eCollection 2024.
2
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective study.利妥昔单抗维持治疗抗中性粒细胞胞浆抗体相关性血管炎期间的复发及严重不良事件：一项多中心回顾性研究
Rheumatology (Oxford). 2025 Apr 1;64(4):1989-1998. doi: 10.1093/rheumatology/keae409.
3
Type of ANCA May Be Indispensable in Distinguishing Subphenotypes of Different Clinical Entities in ANCA-Associated Vasculitis.抗中性粒细胞胞浆抗体（ANCA）类型在区分ANCA相关性血管炎不同临床实体的亚表型中可能不可或缺。
Life (Basel). 2022 Sep 21;12(10):1467. doi: 10.3390/life12101467.
4
Association between renal-limited vasculitis and relapse of antineutrophil cytoplasmic antibody-associated vasculitis: A single-center retrospective cohort study in Japan.肾血管炎与抗中性粒细胞胞质抗体相关性血管炎复发的相关性：日本单中心回顾性队列研究。
PLoS One. 2022 Sep 29;17(9):e0274483. doi: 10.1371/journal.pone.0274483. eCollection 2022.
5
Diagnostic and Therapeutic Approach in ANCA-Associated Glomerulonephritis: A Review on Management Strategies.抗中性粒细胞胞浆抗体相关肾小球肾炎的诊断与治疗方法：管理策略综述
Front Med (Lausanne). 2022 Jun 3;9:884188. doi: 10.3389/fmed.2022.884188. eCollection 2022.
6
Predictors of renal and patient outcomes in anti-neutrophil cytoplasmic antibody-associated vasculitis: Our single-center, tertiary care experience.抗中性粒细胞胞浆抗体相关性血管炎患者肾脏及整体预后的预测因素：我们的单中心三级医疗经验
Arch Rheumatol. 2021 May 11;36(3):445-457. doi: 10.46497/ArchRheumatol.2021.8687. eCollection 2021 Sep.
7
Association between sinusitis and relapse and changes in the myeloperoxidase-antineutrophil cytoplasmic antibody in microscopic polyangiitis.显微镜下多血管炎中鼻窦炎与复发及髓过氧化物酶-抗中性粒细胞胞质抗体变化的关系。
PLoS One. 2020 Dec 10;15(12):e0243572. doi: 10.1371/journal.pone.0243572. eCollection 2020.
Zotero 插件